6.3
Impact
STOCKCorporate News· 1m ago ·Neutral
NATCO Pharma submits investor presentation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NATCO Pharma has informed that it enclosed the Investor Presentation. The…
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NATCO Pharma has informed that it enclosed the Investor Presentation. The above information is a part of company’s filings submitted to BSE.
Impact score breakdown
6.3/10Sentiment strength
42
Market reach
33
Source credibility
90
Recency
100
Market move
0
⚠️ For information only — verify independently before investing. Not investment advice. We are not responsible for any errors.